Tailored Solutions for GLP-1 RA Research for GLP-1 RA Research Whether you're studying weight loss efficacy, glycemic control, cardiovascular outcomes, or quality of life improvements, Signant Health's ePRO solutions deliver: Robust data collection for primary and secondary endpoints Expert input from our team of 50+ clinicians and COA scientists to drive highest quality evidence generation Evidence generation to support for health technology assessments and economic evaluations 24/7 global patient and site support Seamless integration of decentralized trial elements, such as eConsent, TeleVisits, and more
Vlachou E, Ntikoudi A, Owens DA, Nikolakopoulou M, Chalimourdas T, Cauli O
What should I do if the RetaOne Labs code still doesnt work
With the right support, they rarely interfere with ongoing treatment
, ,
GLP-1s are effective for weight loss, and at lower doses combined with ongoing support, theyre more sustainable